Published in J Neuroimmunol on August 01, 2002
Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Med (2007) 1.89
Impaired interferon signaling is a common immune defect in human cancer. Proc Natl Acad Sci U S A (2009) 1.66
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. J Neuroinflammation (2012) 1.52
Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients. PLoS One (2008) 1.43
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest (2009) 1.10
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J Neurol Sci (2011) 1.06
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest (2008) 1.05
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis. Pharmacogenomics J (2012) 1.04
Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J Virol (2008) 1.01
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol (2011) 1.01
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. PLoS One (2010) 1.00
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology. Front Immunol (2013) 0.89
Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE. J Neuroimmune Pharmacol (2009) 0.89
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol (2012) 0.88
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases. Gene (2015) 0.87
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol (2012) 0.85
Expression of biomarkers of interferon type I in patients suffering from chronic diseases. Clin Exp Immunol (2007) 0.83
Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. Clin Immunol (2009) 0.83
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplant (2014) 0.81
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies. J Neurol (2007) 0.80
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients. PLoS One (2014) 0.80
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients. J Neurol Sci (2011) 0.79
The molecular study of IFNβ pleiotropic roles in MS treatment. Iran J Neurol (2013) 0.79
Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer. Immunology (2015) 0.78
Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells. BMC Cancer (2014) 0.78
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms. J Interferon Cytokine Res (2014) 0.77
Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patients. PLoS One (2013) 0.75
The control of reactive oxygen species production by SHP-1 in oligodendrocytes. Glia (2015) 0.75
EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. Nat Cell Biol (2004) 4.55
Role of subconcussion in repetitive mild traumatic brain injury. J Neurosurg (2013) 3.79
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci (2010) 3.38
Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science (2013) 3.35
Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell (2013) 2.71
SAP protein-dependent natural killer T-like cells regulate the development of CD8(+) T cells with innate lymphocyte characteristics. Immunity (2010) 2.47
Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med (2006) 2.22
Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis. Mult Scler (2004) 2.21
Evidence-based medicine: promise and pitfalls. Mult Scler (2012) 2.07
Appalachian mountaintop mining particulate matter induces neoplastic transformation of human bronchial epithelial cells and promotes tumor formation. Environ Sci Technol (2014) 2.00
Cataract surgery for the developing world. Curr Opin Ophthalmol (2008) 1.93
The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development (2006) 1.88
Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat Med (2013) 1.84
Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke (2011) 1.54
Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res (2004) 1.52
Assisted reproductive technology surveillance - United States, 2004. MMWR Surveill Summ (2007) 1.43
Affordable simulation for small-scale training and assessment. Simul Healthc (2010) 1.42
Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons. Eur J Neurosci (2012) 1.42
Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent "innate" gammadelta T cells. PLoS One (2010) 1.41
The utility of quantitative magnetic resonance angiography in the assessment of intracranial in-stent stenosis. Stroke (2009) 1.41
Accuracy of assisted reproductive technology information on the Massachusetts birth certificate, 1997-2000. Fertil Steril (2009) 1.38
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurol (2010) 1.37
Computational and experimental identification of mirtrons in Drosophila melanogaster and Caenorhabditis elegans. Genome Res (2010) 1.31
A FERM domain autoregulates Drosophila myosin 7a activity. Proc Natl Acad Sci U S A (2009) 1.29
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation. BMC Neurol (2012) 1.18
Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial. Contraception (2005) 1.16
AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorg Med Chem Lett (2011) 1.13
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents. PLoS One (2011) 1.13
Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther (2005) 1.13
Solitaire Flow Restoration thrombectomy for acute ischemic stroke: retrospective multicenter analysis of early postmarket experience after FDA approval. Neurosurgery (2013) 1.13
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology (2013) 1.12
The spectrum of neurobehavioral sequelae after repetitive mild traumatic brain injury: a novel mouse model of chronic traumatic encephalopathy. J Neurotrauma (2014) 1.12
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.09
Speaking for Taiwan about colours, maps and politics. Nature (2006) 1.08
The Pipeline Embolization Device for the treatment of posterior circulation fusiform aneurysms: lessons learned at a single institution. J Neurosurg (2014) 1.08
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents. PLoS One (2012) 1.08
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J Neurol Sci (2011) 1.06
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV. Bioorg Med Chem Lett (2013) 1.05
Cystoid macular edema associated with fingolimod use for multiple sclerosis. JAMA Ophthalmol (2013) 1.02
An overview of the basic science of concussion and subconcussion: where we are and where we are going. Neurosurg Focus (2012) 1.01
Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin. Muscle Nerve (2011) 1.01
Impaired wound healing in an acute diabetic pig model and the effects of local hyperglycemia. Wound Repair Regen (2008) 1.01
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 1.00
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study. BMJ Open (2012) 1.00
Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor. Mol Pharmacol (2012) 1.00
Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact. Brain Res (2010) 1.00
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica. J Neuroophthalmol (2012) 0.99
Validation of an inductively coupled plasma mass spectrometry (ICP-MS) method for the determination of cerium, strontium, and titanium in ceramic materials used in radiological dispersal devices (RDDs). Anal Chim Acta (2007) 0.98
IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions. J Neuroimmunol (2008) 0.95
Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Front Neurol (2013) 0.95
Effects of resident duty-hours restrictions on surgical and nonsurgical teaching faculty. Arch Surg (2007) 0.95
Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr (2010) 0.95
Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice. Am J Physiol Gastrointest Liver Physiol (2008) 0.93
Regulation of microtubules by Rho GTPases in migrating cells. Novartis Found Symp (2005) 0.93
Developmental programming by maternal insulin resistance: hyperinsulinemia, glucose intolerance, and dysregulated lipid metabolism in male offspring of insulin-resistant mice. Diabetes (2013) 0.93
Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS. PLoS One (2011) 0.92
Fingolimod for the treatment of relapsing multiple sclerosis. Expert Rev Neurother (2010) 0.91
Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study. Prim Care Companion J Clin Psychiatry (2005) 0.89
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study. Clin Ther (2009) 0.89
Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats. Diabetes (2012) 0.88
4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitis. Neurology (2009) 0.88
The role of circle of Willis anomalies in cerebral aneurysm rupture. J Neurointerv Surg (2011) 0.88
Multiple sclerosis. Part I: neuro-ophthalmic manifestations. Curr Opin Ophthalmol (2009) 0.88
Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study. Am J Geriatr Pharmacother (2005) 0.87
Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificity. Front Biosci (2004) 0.86
Intra-arterial thrombolysis or stent placement during endovascular treatment for acute ischemic stroke leads to the highest recanalization rate: results of a multicenter retrospective study. Neurosurgery (2011) 0.86
Importance of the TIMI frame count: implications for future trials. Curr Control Trials Cardiovasc Med (2000) 0.86
Endothelial nitric oxide production during in vitro simulation of external limb compression. Am J Physiol Heart Circ Physiol (2002) 0.86
Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Curr Med Res Opin (2004) 0.86
Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling. Int J Cell Biol (2011) 0.85
Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol (2012) 0.85
Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command. Curr Med Res Opin (2009) 0.85
Essential role of IL-10/STAT3 in chronic stress-induced immune suppression. Brain Behav Immun (2014) 0.84
The validation of a caregiver assessment of dementia: the Dementia Severity Scale. Alzheimer Dis Assoc Disord (2005) 0.84
Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseases. J Interferon Cytokine Res (2002) 0.84
Experimental robustness of Fourier ptychography phase retrieval algorithms. Opt Express (2015) 0.84
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b. Mult Scler (2009) 0.83
Evaluating insulin secretagogues in a humanized mouse model with functional human islets. Metabolism (2012) 0.83
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine. J Vet Diagn Invest (2002) 0.83
Horizontal Neuroform stent deployment for a ruptured basilar terminus aneurysm via the posterior communicating artery. J Vasc Interv Radiol (2006) 0.82
Younger age of menopause in women with cerebral aneurysms. J Neurointerv Surg (2012) 0.82
Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b. J Interferon Cytokine Res (2014) 0.81
Corrigendum: Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med (2016) 0.81
Cumulative effects of repetitive mild traumatic brain injury. Prog Neurol Surg (2014) 0.81
Outcomes after anterior cervical discectomy and fusion in professional athletes. Neurosurgery (2013) 0.81
IRAS is an anti-apoptotic protein. Ann N Y Acad Sci (2003) 0.81
Fine-mapping reveals novel alternative splicing of the dopamine transporter. Am J Med Genet B Neuropsychiatr Genet (2010) 0.80
Major neurologic improvement following endovascular recanalization therapy for acute ischemic stroke. Cerebrovasc Dis (2008) 0.80
MxA: a biomarker for predicting multiple sclerosis disease activity. Neurology (2010) 0.80
Gender differences in cerebral aneurysm location. Front Neurol (2012) 0.79
Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis. Neurology (2004) 0.79
Factors influencing the implementation of anterior cruciate ligament injury prevention strategies by girls soccer coaches. J Strength Cond Res (2013) 0.79
Vascular neurologists and neurointerventionalists on endovascular stroke care: polling results. Neurology (2012) 0.79
Inhibition of hepatic organic anion-transporting polypeptide by RNA interference in sandwich-cultured human hepatocytes: an in vitro model to assess transporter-mediated drug-drug interactions. Drug Metab Dispos (2010) 0.78
Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS. Ann N Y Acad Sci (2003) 0.78
Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Life Sci (2009) 0.78
An electrically tunable imaging system with separable focus and zoom functions using composite liquid crystal lenses. Opt Express (2014) 0.78